Synaptics Incorporated filings document results reporting, governance changes, capital-structure actions and proxy disclosures for the semiconductor company. Form 8-K reports furnish quarterly and annual operating results, supplemental earnings materials and related GAAP and non-GAAP measures tied to revenue, margins, expenses and per-share results.
Other filings cover board-approved share repurchase authorization, amendments to bylaws, universal-proxy and advance-notice provisions, remote meeting mechanics, uncertificated shares and an exclusive-forum provision under Delaware corporate law. The definitive proxy statement documents shareholder voting matters, director elections, executive compensation, equity awards and pay-versus-performance disclosures.
SYNAPTICS Inc (SYNA) reports an amended insider ownership disclosure by Vice President and Corporate Controller Esther Song. The amendment corrects her beneficial ownership of common stock to 21,591 shares, removing 776 performance stock units that were previously included due to an administrative error. The filing explains that these performance stock units were not earned because the applicable performance goals were not achieved, so this amendment updates the reported holdings rather than recording a new purchase or sale.
SYNAPTICS Inc (SYNA) reports an amended ownership statement for senior executive Satish Ganesan. The amendment corrects his beneficially owned Common Stock holdings to 95,973 shares following removal of 4,108 performance stock units that had been inadvertently included. The company states those performance stock units were not earned because the applicable performance goals were not achieved.
SYNAPTICS Inc (SYNA) reports an amended ownership statement for officer Vikram Gupta. The amendment corrects the amount of securities beneficially owned to 98,431 shares of Common Stock, removing 5,665 performance stock units that had been inadvertently included and were not earned because the applicable performance goals were not achieved.
SYNAPTICS Inc (SYNA) reported an amended insider ownership filing for officer Lisa Bodensteiner, Senior Vice President, Chief Legal Officer and Corporate Secretary. The amendment corrects the number of securities beneficially owned by removing 3,313 performance stock units that had been inadvertently included. These units were not earned because the applicable performance goals were not achieved. Following this correction, Bodensteiner is shown as directly holding 81,654 shares of common stock.
SYNAPTICS Inc (SYNA) received a notice that Rahul Patel plans to sell up to 4,552 shares of its common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on or about 08/19/2026 on the NASDAQ, with an aggregate market value listed as $477,186.16.
The shares relate to Restricted Stock Units with a listed date of 07/17/2026 and the issuer identified as SYNAPTICS Inc. The filing also notes prior 10b5-1 sales during the past three months, including a transaction on 07/20/2026 for 4,554 shares of common stock totaling $523,047.39.
SYNAPTICS Inc (SYNA) received a notice from officer Lisa Bodensteiner of her intent to sell company common stock under Rule 144. The filing lists up to 6,056 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, with a stated market value of $669,672.48 as of August 18, 2026, on NASDAQ. The notice also ties these shares to recently acquired equity awards, including restricted stock units and performance stock units dated August 17, 2026, and discloses prior 10b5-1 plan sales over the preceding three months.
SYNAPTICS Inc (SYNA) executive Vikram Gupta filed a notice of proposed sale of 4,277 shares of common stock through Morgan Stanley Smith Barney. The shares, with an aggregate market value of $472,950.66, are expected to be sold on or about 08/18/2026 on NASDAQ under Rule 144.
SYNAPTICS Inc (SYNA) received a Rule 144 notice from Esther Song covering a proposed sale of its common stock. The filing lists 437 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $48,323.46, expected on August 18, 2026 on NASDAQ. The shares relate to restricted and performance stock units from the issuer.
The notice also reports prior sales of SYNAPTICS common stock by Esther Song during the last three months under a Rule 10b5-1 trading plan, including 126 shares for $17,423.28 on June 18, 2026, and 8,833 shares for $1,246,957.50 on May 28, 2026.
ON Semiconductor Corporation and Synaptics Incorporated report a key regulatory step for their planned merger. The Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period for the transaction on August 12, 2026, following HSR filings made on July 17, 2026.
Under the Agreement and Plan of Reorganization, Sonic Acquisition Corp., a wholly owned onsemi subsidiary, will merge with and into Synaptics, which will survive as a wholly owned onsemi subsidiary. Closing still depends on remaining conditions in the Merger Agreement, including approval by Synaptics stockholders and certain additional regulatory approvals or clearances. The parties continue to expect the merger to close in mid-2027, subject to satisfaction or waiver of these conditions.
Synaptics Incorporated and onsemi describe the strategic rationale for their proposed business combination, emphasizing that onsemi views Synaptics as an AI‑first compute franchise that complements its existing AI data center, automotive and core businesses. Management states that Synaptics’ transformed business over the past five years and its margins and free cash flow are expected to support growth of onsemi’s Astra AI compute platform without diverting R&D from onsemi’s core.
onsemi’s CEO and CFO reiterate that the deal is intended to be accretive to gross margin, cash‑flow positive and scalable through onsemi’s distribution network and manufacturing footprint. They reference planned $200 million of synergies targeted around an 18‑month mark to achieve accretion, with additional manufacturing, margin and revenue synergies anticipated beyond that period. The communication also outlines extensive risk factors, regulatory and stockholder approvals, and directs investors to the forthcoming Form S‑4 registration statement and proxy statement/prospectus for full details.